Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer.

Gulley J, Chen AP, Dahut W, Arlen PM, Bastian A, Steinberg SM, Tsang K, Panicali D, Poole D, Schlom J, Michael Hamilton J

Open source

DOI
10.1002/pros.10130
Published
2002 Oct 1
Container
The Prostate
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pros.10130,
  title = {Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer.},
  author = {Gulley J and Chen AP and Dahut W and Arlen PM and Bastian A and Steinberg SM and Tsang K and Panicali D and Poole D and Schlom J and Michael Hamilton J},
  year = {2002},
  journal = {The Prostate},
  doi = {10.1002/pros.10130},
  url = {https://doi.org/10.1002/pros.10130}
}

RIS

TY  - JOUR
TI  - Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer.
AU  - Gulley J
AU  - Chen AP
AU  - Dahut W
AU  - Arlen PM
AU  - Bastian A
AU  - Steinberg SM
AU  - Tsang K
AU  - Panicali D
AU  - Poole D
AU  - Schlom J
AU  - Michael Hamilton J
PY  - 2002
JO  - The Prostate
DO  - 10.1002/pros.10130
UR  - https://doi.org/10.1002/pros.10130
ER  - 

APA

J, G., AP, C., W, D., PM, A., A, B., SM, S., K, T., D, P., D, P., J, S., & J, M. H. (2002). Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer.. The Prostate. https://doi.org/10.1002/pros.10130

Source records